市場調査レポート
商品コード
1499605
関節置換術の市場:固定タイプ、関節タイプ、材料、手技、エンドユーザー別-2024-2030年の世界予測Joint Replacement Market by Fixation Type (Cemented, Cementless, Hybrid), Joint Type (Ankle Replacement, Finger or Hand Joints Replacement, Hip Replacement), Material, Procedure, End-Use - Global Forecast 2024-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
関節置換術の市場:固定タイプ、関節タイプ、材料、手技、エンドユーザー別-2024-2030年の世界予測 |
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
|
関節置換術市場規模は2023年に182億5,000万米ドルと推計され、2024年には192億2,000万米ドルに達し、CAGR 5.45%で2030年には264億7,000万米ドルに達すると予測されています。
関節置換術は、損傷したり機能不全に陥ったりした関節を人工関節に置き換える外科手術です。関節置換術は、重度の関節痛や退行性関節疾患に苦しむ人々の痛みを和らげ、可動性を向上させ、生活の質を高めるのに役立っています。人工関節置換術の主な用途は医療分野であり、特に、様々な疾患による激しい関節痛や運動不能に苦しむ患者の治療に用いられています。特に高齢者の間で変形性関節症や関節リウマチの有病率が増加しているため、関節置換術手術の必要性が高まっており、市場成長の基盤となっています。関節置換術手術に対する意識の高まりと、手術に関連する償還政策の利用可能性が、市場の成長をさらに促進しています。代替治療の選択肢や術後の合併症やリスクが市場成長の妨げとなっています。手術手技における技術革新の高まりと、手術の結果を改善する補綴設計の強化が、市場成長の機会を生み出すと期待されています。また、耐久性と人体への適合性に優れた素材を使用することも、市場の成長に寄与すると期待されています。
主な市場の統計 | |
---|---|
基準年[2023] | 182億5,000万米ドル |
予測年[2024] | 192億2,000万米ドル |
予測年 [2030] | 264億7,000万米ドル |
CAGR(%) | 5.45% |
地域別の洞察
南北アメリカは、変形性関節症や肥満など、関節の変性につながる疾患の有病率上昇を管理する必要性が高まっていることを主因として、人工股関節置換術や人工膝関節置換術の分野で非常に発展している地域です。先進的なヘルスケア・インフラと高い医療費も、南北アメリカにおける人工股関節置換術と人工膝関節置換術の大きな市場を支えています。APAC地域では、高齢者人口の増加、医療水準の向上、経済状況の改善により、関節置換術市場が急成長しています。中国、インド、日本を含む国々は、医療施設へのアクセスの向上と、健康ソリューションへの投資を厭わない中間層の台頭の恩恵を受けており、関節置換術手術へのアクセスも拡大しています。欧州は関節置換術の新興国市場であり、高度なヘルスケアシステムと関節置換術手術に対する高い認知度があります。支援的な医療保険と償還政策もEMEAの市場成長に寄与しています。中東およびアフリカでは、ヘルスケアインフラの改善や医療サービスに対する政府の取り組みが影響し、関節置換術市場が成長しています。
FPNVポジショニング・マトリックス
FPNVポジショニングマトリックスは、関節置換術市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。
市場シェア分析
市場シェア分析は、関節置換術市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。
戦略分析と推奨
戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、関節置換術市場における現在の立ち位置を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。
[185 Pages Report] The Joint Replacement Market size was estimated at USD 18.25 billion in 2023 and expected to reach USD 19.22 billion in 2024, at a CAGR 5.45% to reach USD 26.47 billion by 2030.
Joint replacement is a surgical procedure in which damaged or dysfunctional joints are replaced with prosthetics. Joint replacement helps to relieve pain, improve mobility, and enhance the quality of life for individuals suffering from severe joint pain or degenerative joint diseases. The primary application of joint replacements is in the medical field, particularly in treating patients suffering from severe joint pain and immobility due to various conditions. The increased prevalence of osteoarthritis and rheumatoid arthritis, especially among the elderly population, is raising the need for joint replacement surgeries, creating a platform for market growth. Growing awareness about joint replacement surgeries and the availability of reimbursement policies associated with surgeries are further driving the market's growth. The availability of alternative treatment options and certain post-surgery complications and risks hamper the market growth. Rising innovations in surgical techniques and enhancements in prosthetic design that improve the outcomes of joint replacement surgeries are expected to create opportunities for market growth. Using materials that offer greater durability and compatibility with the human body is also expected to contribute to the market's growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 18.25 billion |
Estimated Year [2024] | USD 19.22 billion |
Forecast Year [2030] | USD 26.47 billion |
CAGR (%) | 5.45% |
Regional Insights
Americas represents a highly developing landscape for joint replacement surgeries, primarily due to an increasing need to manage the rising prevalence of conditions including osteoarthritis and obesity that contribute to joint degeneration. Advanced healthcare infrastructure and higher healthcare expenditure also support a large market for both hip and knee replacement surgeries in the Americas. The APAC region is experiencing rapid growth in the joint replacement market due to an increasing elderly population, rising healthcare standards, and improving economic conditions contribute to this growth. Countries including China, India, and Japan have benefitted from the growing accessibility to healthcare facilities and a rising middle class willing to invest in health solutions, subsequently expanding the accessibility of joint replacement surgeries. Europe is a developing market for joint replacement with advanced healthcare systems and high awareness of joint replacement procedures. Supportive health insurance and reimbursement policies also contribute to the market growth in EMEA. The Middle East and Africa have a growing joint replacement market, influenced by improving healthcare infrastructure and government initiatives towards health services.
Market Insights
The market dynamics represent an ever-changing landscape of the Joint Replacement Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Joint Replacement Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Joint Replacement Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Intellijoint Surgical Expands Market Reach with Intellijoint KNEE Approval in Japan
Intellijoint Surgical received regulatory approval in Japan for its innovative product, Intellijoint KNEE, marking a significant expansion in the global computer-assisted surgical navigation market. This technology offers orthopedic surgeons real-time, accurate measurements for surgical cutting guides during total knee replacements. It is adaptable to all implant brands, enhancing its integration into existing surgical workflows. [Published On: 2024-03-07]
FDA Approval Enhances Treatment for Early-Stage Knee Osteoarthritis
The U.S. Food and Drug Administration (FDA) approved the MISHA Knee System, an implantable device designed to alleviate symptoms of early-stage knee osteoarthritis. Specifically targeting patients experiencing persistent pain despite conventional nonsurgical interventions, such as weight loss and physical therapy, this device strategically reduces the weight-bearing load by one-third on the medial side of the knee, thereby lessening joint stress. Primarily aimed at patients not yet requiring total knee replacement, the MISHA Knee System is a transitional solution, potentially delaying the need for more invasive procedures and appealing particularly to younger, active individuals. [Published On: 2023-04-25]
Aster Medcity Introduces Robotic Technology for Knee Replacement Surgeries
Aster Medcity introduced a state-of-the-art, fully automated robot designed explicitly for high-precision knee replacement surgeries. Knee replacement surgery, typically advised for severe joint pain unresponsive to standard treatments, involves replacing the damaged joint surfaces to alleviate discomfort and improve mobility. This robotic system promises to refine this procedure by ensuring increased accuracy and potentially better patient recovery rates. [Published On: 2023-01-23]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Joint Replacement Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Joint Replacement Market, highlighting leading vendors and their innovative profiles. These include Aditi Corporation, Aesculap, Inc., Arthrex, Inc., B. Braun SE, Corin Group, DJO Global Inc., Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kyocera Corporation, Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, NuVasive Inc., Orthofix Medical Inc., Smith & Nephew PLC, Stryker Corporation, Uteshiya Medicare Private Limited, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage